Shares of Ocugen Inc. OCGN, -9.62% slid 9.62% to $2.63 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX, -0.30% falling 0.30% to 3,790.38 and Dow Jones Industrial Average DJIA, -0.46% falling 0.46% to 30,630.17. Ocugen Inc. closed $15.02 short of its 52-week high ($17.65), which the company achieved on November 3rd.
The stock underperformed when compared to some of its competitors Thursday, as Adverum Biotechnologies Inc. ADVM, remained unchanged, Ocular Therapeutix Inc. OCUL, -4.23% fell 4.23% to $4.30, and Kodiak Sciences Inc. KOD, -0.44% fell 0.44% to $9.10. Trading volume (4.4 M) remained 2.6 million below its 50-day average volume of 7.0 M.